Elizabeth Ann Barrett
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth Ann Barrett has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Sofie Ragnhild Aminoff
Early Intervention in Psychosis Advisory Unit for South East Norway, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
5 shared publications - Carmen Simonsen
Early Intervention in Psychosis Advisory Unit for South East Norway, Division of Mental Health and Addiction, Oslo University Hospital, Sognsvannsveien 21, Bygg 12, 2. etg, Oslo, 0372, Norway, 47 93624119
4 shared publications - Erlend Mork
Early Intervention in Psychosis Advisory Unit for South East Norway, Division of Mental Health and Addiction, Oslo University Hospital, Sognsvannsveien 21, Bygg 12, 2. etg, Oslo, 0372, Norway, 47 93624119
4 shared publications - Ingrid Melle
Oslo University Hospital & Institute of Clinical Medicine, University of Oslo
4 shared publications - Kari Jorunn Kværner
Early Intervention in Psychosis Advisory Unit for South East Norway, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
4 shared publications - Kristin Lie Romm
Early Intervention in Psychosis Advisory Unit for South East Norway, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway
4 shared publications
Latest Publications
- Open Access
- 22 June 2026
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 25
Wish list from people with lived experience of bipolar disorder - for clinicians and researchers
- 22 June 2026
- Published by Elsevier in Journal of Affective Disorders Reports
- Vol. 25
Open AccessWish list from people with lived experience of bipolar disorder - for clinicians and researchers
- Open Access
- 11 July 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e68813
A Mobile App Designed to Promote Shared Decision-Making in the Treatment of Psychotic Disorders: Feasibility and Acceptability Study
Background: Strengthening shared decision-making in mental health care may improve the quality of services and treatment outcomes, but its implementation in services for severe mental disorders is currently lacking. Objective: This study aims to explore the feasibility and acceptability of iTandem (University of Oslo), a mobile app designed to promote shared decision-making in the treatment of psychotic disorders. In addition, the study aims to investigate mechanisms that potentially contribute to the intended effect of the app. iTandem is a therapy supplement that facilitates patient involvement in decisions regarding treatment goals and focus areas. It is designed for personalized use and contains 8 optional modules: sleep, medication, recovery, mood, psychosis, activity, substance use, and feedback concerning therapy. Methods: Patients undergoing assessment or treatment for psychotic disorders and their clinicians were recruited for the study. Patients and clinicians jointly used iTandem as part of standard treatment in a 6-week trial. We used a mixed-methods study design with a clear emphasis on qualitative methods. Feasibility and acceptability were assessed through descriptive statistics based on preintervention and postintervention questionnaires and app usage data, in addition to text responses to open-ended items. We conducted a reflexive thematic analysis of postintervention interviews to elaborate these measures and to explore mechanisms potentially contributing to achieving shared decision-making when using iTandem. Results: A total of 9 patients and 8 clinicians completed the trial. The participants evaluated iTandem as a user-friendly and acceptable tool, but there were considerable variations in how the app was integrated into treatment and in perceptions of its clinical value. The thematic analysis suggests that iTandem has the potential to facilitate shared decision-making through supporting cognition and shifting the patient’s role. We also identified scaffolding structures, an analogy of personalized support, as a precondition for these mechanisms and for the overall feasibility and acceptability of iTandem. Conclusions: iTandem was generally perceived as a feasible and acceptable tool in the treatment of patients with psychotic disorders. Our findings suggest that nonclinical aspects, such as support structures, are important to the feasibility and acceptability of such digital interventions and patients’ aptness for digitalized treatment in general. Future research should explore related nonclinical aspects further instead of defining potential target groups based on diagnoses and symptom severity alone.
- 11 July 2025
- Published by JMIR Publications Inc. in JMIR Human Factors
- Vol. 12 (1) , e68813
Open AccessA Mobile App Designed to Promote Shared Decision-Making in the Treatment of Psychotic Disorders: Feasibility and Acceptability Study
Background: Strengthening shared decision-making in mental health care may improve the quality of services and treatment outcomes, but its implementation in services for severe mental disorders is currently lacking. Objective: This study aims to explore the feasibility and acceptability of iTandem (University of Oslo), a mobile app designed to promote shared decision-making in the treatment of psychotic disorders. In addition, the study aims to investigate mechanisms that potentially contribute to the intended effect of the app. iTandem is a therapy supplement that facilitates patient involvement in decisions regarding treatment goals and focus areas. It is designed for personalized use and contains 8 optional modules: sleep, medication, recovery, mood, psychosis, activity, substance use, and feedback concerning therapy. Methods: Patients undergoing assessment or treatment for psychotic disorders and their clinicians were recruited for the study. Patients and clinicians jointly used iTandem as part of standard treatment in a 6-week trial. We used a mixed-methods study design with a clear emphasis on qualitative methods. Feasibility and acceptability were assessed through descriptive statistics based on preintervention and postintervention questionnaires and app usage data, in addition to text responses to open-ended items. We conducted a reflexive thematic analysis of postintervention interviews to elaborate these measures and to explore mechanisms potentially contributing to achieving shared decision-making when using iTandem. Results: A total of 9 patients and 8 clinicians completed the trial. The participants evaluated iTandem as a user-friendly and acceptable tool, but there were considerable variations in how the app was integrated into treatment and in perceptions of its clinical value. The thematic analysis suggests that iTandem has the potential to facilitate shared decision-making through supporting cognition and shifting the patient’s role. We also identified scaffolding structures, an analogy of personalized support, as a precondition for these mechanisms and for the overall feasibility and acceptability of iTandem. Conclusions: iTandem was generally perceived as a feasible and acceptable tool in the treatment of patients with psychotic disorders. Our findings suggest that nonclinical aspects, such as support structures, are important to the feasibility and acceptability of such digital interventions and patients’ aptness for digitalized treatment in general. Future research should explore related nonclinical aspects further instead of defining potential target groups based on diagnoses and symptom severity alone.
- Open Access
- 17 January 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9 (1) , e57614
A Mobile Health Intervention to Support Collaborative Decision-Making in Mental Health Care: Development and Usability
Background: Shared decision-making between clinicians and service users is crucial in mental health care. One significant barrier to achieving this goal is the lack of user-centered services. Integrating digital tools into mental health services holds promise for addressing some of these challenges. However, the implementation of digital tools, such as mobile apps, remains limited, and attrition rates for mental health apps are typically high. Design thinking can support the development of tools tailored to the needs of service users and clinicians. Objective: This study aims to develop and beta test a digital tool designed for individuals with severe mental disorders or substance use disorders to facilitate shared decision-making on treatment goals and strategies within mental health services. Methods: We used a user-centered design approach to develop iTandem, an app facilitating collaborative treatment between service users and clinicians. Through qualitative interviews and workshops, we engaged 6 service users with severe mental disorders or substance use disorders, 6 clinicians, and 1 relative to identify and design relevant app modules. A beta test of iTandem was conducted to refine the app and plan for a pilot trial in a clinical setting. After 6 weeks of app use, 5 clinicians and 4 service users were interviewed to provide feedback on the concept, implementation, and technical issues. Safety and ethical considerations were thoroughly discussed and addressed. Results: To avoid overload for the service users, we applied a pragmatic take on module content and size. Thus, iTandem includes the following 8 modules, primarily based on the needs of service users and clinicians: Sleep (sleep diary), Medication (intake and side effects), Recovery (measures, including well-being and personal recovery, and exercises, including good things and personal strengths), Mood (mood diary and report of daily feelings), Psychosis (level of positive symptoms and their consequences and level of negative symptoms), Activity (goal setting and progress), Substance use (weekly use, potential triggers or strategies used to abstain), and Feedback on therapy (of individual sessions and overall rating of the past week). For the beta testing, service users and clinicians collaborated in choosing 2-3 modules in iTandem to work with during treatment sessions. The testing showed that the app was well received by service users, and that facilitation for implementation is crucial. Conclusions: iTandem and similar apps have the potential to enhance treatment outcomes by facilitating shared decision-making and tailoring treatment to the needs of service users. However, successful implementation requires thorough testing, iterative development, and evaluations of both utility and treatment effects. There is a critical need to focus on how technology integrates into clinical settings—from development to implementation—and to conduct further research on early health technology assessments to guide these processes.
- 17 January 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9 (1) , e57614
Open AccessA Mobile Health Intervention to Support Collaborative Decision-Making in Mental Health Care: Development and Usability
Background: Shared decision-making between clinicians and service users is crucial in mental health care. One significant barrier to achieving this goal is the lack of user-centered services. Integrating digital tools into mental health services holds promise for addressing some of these challenges. However, the implementation of digital tools, such as mobile apps, remains limited, and attrition rates for mental health apps are typically high. Design thinking can support the development of tools tailored to the needs of service users and clinicians. Objective: This study aims to develop and beta test a digital tool designed for individuals with severe mental disorders or substance use disorders to facilitate shared decision-making on treatment goals and strategies within mental health services. Methods: We used a user-centered design approach to develop iTandem, an app facilitating collaborative treatment between service users and clinicians. Through qualitative interviews and workshops, we engaged 6 service users with severe mental disorders or substance use disorders, 6 clinicians, and 1 relative to identify and design relevant app modules. A beta test of iTandem was conducted to refine the app and plan for a pilot trial in a clinical setting. After 6 weeks of app use, 5 clinicians and 4 service users were interviewed to provide feedback on the concept, implementation, and technical issues. Safety and ethical considerations were thoroughly discussed and addressed. Results: To avoid overload for the service users, we applied a pragmatic take on module content and size. Thus, iTandem includes the following 8 modules, primarily based on the needs of service users and clinicians: Sleep (sleep diary), Medication (intake and side effects), Recovery (measures, including well-being and personal recovery, and exercises, including good things and personal strengths), Mood (mood diary and report of daily feelings), Psychosis (level of positive symptoms and their consequences and level of negative symptoms), Activity (goal setting and progress), Substance use (weekly use, potential triggers or strategies used to abstain), and Feedback on therapy (of individual sessions and overall rating of the past week). For the beta testing, service users and clinicians collaborated in choosing 2-3 modules in iTandem to work with during treatment sessions. The testing showed that the app was well received by service users, and that facilitation for implementation is crucial. Conclusions: iTandem and similar apps have the potential to enhance treatment outcomes by facilitating shared decision-making and tailoring treatment to the needs of service users. However, successful implementation requires thorough testing, iterative development, and evaluations of both utility and treatment effects. There is a critical need to focus on how technology integrates into clinical settings—from development to implementation—and to conduct further research on early health technology assessments to guide these processes.
- Open Access
- 14 November 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Promoting Shared Decision-Making in Treatment for Psychotic Disorders with the iTandem Mobile App: A Feasibility and Acceptability Study (Preprint)
BACKGROUND Strengthening shared decision-making in mental healthcare may improve quality of services and treatment outcomes, but its implementation in services for severe mental disorders is currently lacking. OBJECTIVE This study aims to explore the feasibility and acceptability of the mobile app iTandem as a digital tool promoting shared decision-making in treatment for psychotic disorders. In addition, the study aims to investigate mechanisms that enable the intended effect of the app. iTandem is a mobile app developed as a therapy supplement that facilitates patient involvement in decisions regarding treatment goals and focus areas. It is designed for personalized use and contains eight optional modules: sleep, medication, recovery, mood, psychosis, activity, substance use, and feedback concerning therapy. METHODS Patients undergoing assessment or treatment for psychotic disorders and their clinicians were recruited to the study. The patients and the clinicians jointly used iTandem as part of the standard treatment in a six week-trial. Using a mixed methods design, feasibility and acceptability measures were assessed with descriptive statistics based on app usage data and pre- and post-intervention questionnaires, in addition to a reflexive thematic analysis of post-intervention interviews. RESULTS Nine patients and eight clinicians completed the trial. The participants evaluated iTandem as a user-friendly and acceptable tool, but there were considerable variations in how the app was integrated in treatment and in perceptions of its clinical value. The thematic analysis suggests that iTandem promoted shared decision-making by supporting cognition and shifting the patient role. It also identified scaffolding structures, an analogy of personalised support, as a precondition for the overall feasibility and acceptability of the intervention. CONCLUSIONS iTandem generally functioned as a feasible and acceptable digital promoter of shared decision-making in treatment for patients with psychotic disorders. Our findings suggest that non-clinical aspects, such as support structures, digital habits and personal styles of relating to others are important in evaluations of patients’ aptness for digitalised treatment. Future research should explore these general parameters further, as opposed to grouping potential users based on diagnoses and symptom severity.
- 14 November 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessPromoting Shared Decision-Making in Treatment for Psychotic Disorders with the iTandem Mobile App: A Feasibility and Acceptability Study (Preprint)
BACKGROUND Strengthening shared decision-making in mental healthcare may improve quality of services and treatment outcomes, but its implementation in services for severe mental disorders is currently lacking. OBJECTIVE This study aims to explore the feasibility and acceptability of the mobile app iTandem as a digital tool promoting shared decision-making in treatment for psychotic disorders. In addition, the study aims to investigate mechanisms that enable the intended effect of the app. iTandem is a mobile app developed as a therapy supplement that facilitates patient involvement in decisions regarding treatment goals and focus areas. It is designed for personalized use and contains eight optional modules: sleep, medication, recovery, mood, psychosis, activity, substance use, and feedback concerning therapy. METHODS Patients undergoing assessment or treatment for psychotic disorders and their clinicians were recruited to the study. The patients and the clinicians jointly used iTandem as part of the standard treatment in a six week-trial. Using a mixed methods design, feasibility and acceptability measures were assessed with descriptive statistics based on app usage data and pre- and post-intervention questionnaires, in addition to a reflexive thematic analysis of post-intervention interviews. RESULTS Nine patients and eight clinicians completed the trial. The participants evaluated iTandem as a user-friendly and acceptable tool, but there were considerable variations in how the app was integrated in treatment and in perceptions of its clinical value. The thematic analysis suggests that iTandem promoted shared decision-making by supporting cognition and shifting the patient role. It also identified scaffolding structures, an analogy of personalised support, as a precondition for the overall feasibility and acceptability of the intervention. CONCLUSIONS iTandem generally functioned as a feasible and acceptable digital promoter of shared decision-making in treatment for patients with psychotic disorders. Our findings suggest that non-clinical aspects, such as support structures, digital habits and personal styles of relating to others are important in evaluations of patients’ aptness for digitalised treatment. Future research should explore these general parameters further, as opposed to grouping potential users based on diagnoses and symptom severity.
- Open Access
- 22 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
A Mobile Health Intervention to Support Collaborative Decision-Making in Mental Health Care: Development and Usability (Preprint)
BACKGROUND Shared decision-making between clinicians and service users is crucial in mental health care. One significant barrier to achieving this goal is the lack of user-centered services. Integrating digital tools into mental health services holds promise for addressing some of these challenges. However, the implementation of digital tools, such as mobile apps, remains limited, and attrition rates for mental health apps are typically high. Design thinking can support the development of tools tailored to the needs of service users and clinicians. OBJECTIVE This study aims to develop and beta test a digital tool designed for individuals with severe mental disorders or substance use disorders to facilitate shared decision-making on treatment goals and strategies within mental health services. METHODS We used a user-centered design approach to develop iTandem, an app facilitating collaborative treatment between service users and clinicians. Through qualitative interviews and workshops, we engaged 6 service users with severe mental disorders or substance use disorders, 6 clinicians, and 1 relative to identify and design relevant app modules. A beta test of iTandem was conducted to refine the app and plan for a pilot trial in a clinical setting. After 6 weeks of app use, 5 clinicians and 4 service users were interviewed to provide feedback on the concept, implementation, and technical issues. Safety and ethical considerations were thoroughly discussed and addressed. RESULTS To avoid overload for the service users, we applied a pragmatic take on module content and size. Thus, iTandem includes the following 8 modules, primarily based on the needs of service users and clinicians: Sleep (sleep diary), Medication (intake and side effects), Recovery (measures, including well-being and personal recovery, and exercises, including good things and personal strengths), Mood (mood diary and report of daily feelings), Psychosis (level of positive symptoms and their consequences and level of negative symptoms), Activity (goal setting and progress), Substance use (weekly use, potential triggers or strategies used to abstain), and Feedback on therapy (of individual sessions and overall rating of the past week). For the beta testing, service users and clinicians collaborated in choosing 2-3 modules in iTandem to work with during treatment sessions. The testing showed that the app was well received by service users, and that facilitation for implementation is crucial. CONCLUSIONS iTandem and similar apps have the potential to enhance treatment outcomes by facilitating shared decision-making and tailoring treatment to the needs of service users. However, successful implementation requires thorough testing, iterative development, and evaluations of both utility and treatment effects. There is a critical need to focus on how technology integrates into clinical settings—from development to implementation—and to conduct further research on early health technology assessments to guide these processes.
- 22 February 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Mobile Health Intervention to Support Collaborative Decision-Making in Mental Health Care: Development and Usability (Preprint)
BACKGROUND Shared decision-making between clinicians and service users is crucial in mental health care. One significant barrier to achieving this goal is the lack of user-centered services. Integrating digital tools into mental health services holds promise for addressing some of these challenges. However, the implementation of digital tools, such as mobile apps, remains limited, and attrition rates for mental health apps are typically high. Design thinking can support the development of tools tailored to the needs of service users and clinicians. OBJECTIVE This study aims to develop and beta test a digital tool designed for individuals with severe mental disorders or substance use disorders to facilitate shared decision-making on treatment goals and strategies within mental health services. METHODS We used a user-centered design approach to develop iTandem, an app facilitating collaborative treatment between service users and clinicians. Through qualitative interviews and workshops, we engaged 6 service users with severe mental disorders or substance use disorders, 6 clinicians, and 1 relative to identify and design relevant app modules. A beta test of iTandem was conducted to refine the app and plan for a pilot trial in a clinical setting. After 6 weeks of app use, 5 clinicians and 4 service users were interviewed to provide feedback on the concept, implementation, and technical issues. Safety and ethical considerations were thoroughly discussed and addressed. RESULTS To avoid overload for the service users, we applied a pragmatic take on module content and size. Thus, iTandem includes the following 8 modules, primarily based on the needs of service users and clinicians: Sleep (sleep diary), Medication (intake and side effects), Recovery (measures, including well-being and personal recovery, and exercises, including good things and personal strengths), Mood (mood diary and report of daily feelings), Psychosis (level of positive symptoms and their consequences and level of negative symptoms), Activity (goal setting and progress), Substance use (weekly use, potential triggers or strategies used to abstain), and Feedback on therapy (of individual sessions and overall rating of the past week). For the beta testing, service users and clinicians collaborated in choosing 2-3 modules in iTandem to work with during treatment sessions. The testing showed that the app was well received by service users, and that facilitation for implementation is crucial. CONCLUSIONS iTandem and similar apps have the potential to enhance treatment outcomes by facilitating shared decision-making and tailoring treatment to the needs of service users. However, successful implementation requires thorough testing, iterative development, and evaluations of both utility and treatment effects. There is a critical need to focus on how technology integrates into clinical settings—from development to implementation—and to conduct further research on early health technology assessments to guide these processes.
- Open Access
- 1 November 2021
- Published by Elsevier in Biological Psychiatry
- Vol. 90 (9) , 621-631
Characterizing the Genetic Overlap Between Psychiatric Disorders and Sleep-Related Phenotypes
- 1 November 2021
- Published by Elsevier in Biological Psychiatry
- Vol. 90 (9) , 621-631
Open AccessCharacterizing the Genetic Overlap Between Psychiatric Disorders and Sleep-Related Phenotypes